These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses. Bounds CE; Kwilas SA; Kuehne AI; Brannan JM; Bakken RR; Dye JM; Hooper JW; Dupuy LC; Ellefsen B; Hannaman D; Wu H; Jiao JA; Sullivan EJ; Schmaljohn CS PLoS One; 2015; 10(9):e0137786. PubMed ID: 26422247 [TBL] [Abstract][Full Text] [Related]
8. Serological evidence of exposure to ebolaviruses in domestic pigs from Guinea. Fischer K; Camara A; Troupin C; Fehling SK; Strecker T; Groschup MH; Tordo N; Diederich S Transbound Emerg Dis; 2020 Mar; 67(2):724-732. PubMed ID: 31627257 [TBL] [Abstract][Full Text] [Related]
9. Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay. Sobarzo A; Perelman E; Groseth A; Dolnik O; Becker S; Lutwama JJ; Dye JM; Yavelsky V; Lobel L; Marks RS Clin Vaccine Immunol; 2012 Nov; 19(11):1844-52. PubMed ID: 22993411 [TBL] [Abstract][Full Text] [Related]
10. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine. Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655 [TBL] [Abstract][Full Text] [Related]
11. Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses. Natesan M; Jensen SM; Keasey SL; Kamata T; Kuehne AI; Stonier SW; Lutwama JJ; Lobel L; Dye JM; Ulrich RG Clin Vaccine Immunol; 2016 Aug; 23(8):717-24. PubMed ID: 27335383 [TBL] [Abstract][Full Text] [Related]
12. A Chimeric Sudan Virus-Like Particle Vaccine Candidate Produced by a Recombinant Baculovirus System Induces Specific Immune Responses in Mice and Horses. Wu F; Zhang S; Zhang Y; Mo R; Yan F; Wang H; Wong G; Chi H; Wang T; Feng N; Gao Y; Xia X; Zhao Y; Yang S Viruses; 2020 Jan; 12(1):. PubMed ID: 31947873 [TBL] [Abstract][Full Text] [Related]
14. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Flyak AI; Shen X; Murin CD; Turner HL; David JA; Fusco ML; Lampley R; Kose N; Ilinykh PA; Kuzmina N; Branchizio A; King H; Brown L; Bryan C; Davidson E; Doranz BJ; Slaughter JC; Sapparapu G; Klages C; Ksiazek TG; Saphire EO; Ward AB; Bukreyev A; Crowe JE Cell; 2016 Jan; 164(3):392-405. PubMed ID: 26806128 [TBL] [Abstract][Full Text] [Related]
15. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus. Luczkowiak J; Arribas JR; Gómez S; Jiménez-Yuste V; de la Calle F; Viejo A; Delgado R Virus Res; 2016 Feb; 213():224-229. PubMed ID: 26739425 [TBL] [Abstract][Full Text] [Related]
16. Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques. Marzi A; Fletcher P; Feldmann F; Saturday G; Hanley PW; Feldmann H Lancet Microbe; 2023 Mar; 4(3):e171-e178. PubMed ID: 36739878 [TBL] [Abstract][Full Text] [Related]
17. Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. Macneil A; Reed Z; Rollin PE PLoS Negl Trop Dis; 2011 Jun; 5(6):e1175. PubMed ID: 21666792 [TBL] [Abstract][Full Text] [Related]
18. Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease. Luczkowiak J; Lasala F; Mora-Rillo M; Arribas JR; Delgado R J Infect Dis; 2018 Nov; 218(suppl_5):S574-S581. PubMed ID: 29939289 [TBL] [Abstract][Full Text] [Related]
19. Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus. Ayouba A; Touré A; Butel C; Keita AK; Binetruy F; Sow MS; Foulongne V; Delaporte E; Peeters M J Clin Microbiol; 2017 Jan; 55(1):165-176. PubMed ID: 27795350 [TBL] [Abstract][Full Text] [Related]
20. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma. Gilchuk P; Guthals A; Bonissone SR; Shaw JB; Ilinykh PA; Huang K; Bombardi RG; Liang J; Grinyo A; Davidson E; Chen EC; Gunn BM; Alter G; Saphire EO; Doranz BJ; Bukreyev A; Zeitlin L; Castellana N; Crowe JE Front Immunol; 2021; 12():706757. PubMed ID: 34335620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]